Deal Library / Pharma BD Deal Intelligence

Merck KGaA — Pharma Deals

The Pharma Closeout tracks 8 deals, $48.4B in disclosed deal value, 5 with a post-close Outcome Score for Merck KGaA.

Median Critic Score: 75  ·  Median Outcome Score: 80

Best outcome: Merck KGaA / Millipore Corporation (88)  ·  Weakest outcome: Merck KGaA / SpringWorks Therapeutics (72)

All 8 deals

• Merck KGaA / Millipore Corporation — 2010 · $7.2B · Worked — the deal delivered on its rationale.
• Merck KGaA / Versum Materials — 2019 · $5.8B · Worked — the deal delivered on its rationale.
• Merck KGaA / Sigma-Aldrich Corporation — 2014 · $17.0B · Worked — the deal delivered on its rationale.
• Merck KGaA / Serono SA — 2006 · $13.2B · Largely worked — most objectives met.
• Merck KGaA / SpringWorks Therapeutics — 2025 · $3.4B · Largely worked — most objectives met.
• Merck KGaA / Vertex Pharmaceuticals Incorporated — 2017 · $1.2B
• Merck KGaA / Threshold Pharmaceuticals, Inc. — 2012 · $550M
• Merck KGaA / ImClone Systems Inc. — 2007

← Deal Library  ·  Interactive search  ·  How we score deals